Since extracellular ketone bodies have been found to inhibit tumor growth through various mechanisms, including HDAC inhibition20,33, we next determined whether hepatic PAK4 deficiency-enhanced ketogenesis suppresses tumor growth in in vivo tumor transplantation models; subcutaneous and orthotopic tumor models. The gene discussed is PAK4; the disease is neoplasm.